The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kemp Dolliver's Stock Ratings
Brookline Capital Analyst
Kemp Dolliver is an analyst at Brookline Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-21.4%
Smart Score
Overall Average Return Percentile
10th
Number of Ratings
27
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/19/2025 | RNTX | Buy Now | Rein Therapeutics | $1.48 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 07/21/2025 | RADX | Buy Now | Radiopharm Theranostics | $5.88 | 206.12% | → $18 | Initiates | → Buy | Get Alert | |
| 07/15/2025 | LSTA | Buy Now | Lisata Therapeutics | $2.05 | 1460.98% | $20 → $32 | Maintains | Buy | Get Alert | |
| 12/05/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | → $17 | Initiates | → Buy | Get Alert | |
| 11/15/2024 | EYEN | Buy Now | Eyenovia | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 10/02/2024 | VRCA | Buy Now | Verrica Pharmaceuticals | $8.00 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 09/12/2024 | ONCT | Buy Now | Oncternal Therapeutics | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 07/22/2024 | IBIO | Buy Now | iBio | $1.91 | 88.24% | → $3.6 | Initiates | → Buy | Get Alert | |
| 05/15/2024 | DARE | Buy Now | Dare Bioscience | $2.20 | 36.36% | → $3 | Upgrade | Hold → Buy | Get Alert | |
| 04/17/2024 | DARE | Buy Now | Dare Bioscience | $2.20 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 03/19/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 01/25/2024 | OTLK | Buy Now | Outlook Therapeutics | $2.29 | -31.59% | → $1.57 | Upgrade | Hold → Buy | Get Alert | |
| 12/21/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | $27 → $12.5 | Downgrade | Buy → Hold | Get Alert | |
| 12/19/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 12/04/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | → $2 | Upgrade | Hold → Buy | Get Alert | |
| 11/30/2023 | LNTH | Buy Now | Lantheus Holdings | $65.10 | 53.61% | → $100 | Initiates | → Buy | Get Alert | |
| 10/17/2023 | EYEN | Buy Now | Eyenovia | — | — | → $8 | Initiates | → Buy | Get Alert | |
| 10/12/2023 | EDSA | Buy Now | Edesa Biotech | $1.44 | 3858.33% | → $57 | Maintains | Buy | Get Alert | |
| 09/06/2023 | PROC | Buy Now | Procaps Gr | — | — | → $4.5 | Downgrade | Buy → Hold | Get Alert | |
| 05/18/2023 | GNLX | Buy Now | Genelux | $4.06 | 515.76% | → $25 | Initiates | → Hold | Get Alert | |
| 05/01/2023 | NHWK | Buy Now | NightHawk Biosciences | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 04/04/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 01/13/2023 | ECOR | Buy Now | electroCore | $4.76 | -73.74% | → $1.25 | Initiates | → Buy | Get Alert | |
| 12/16/2022 | EDSA | Buy Now | Edesa Biotech | $1.44 | 802.78% | → $13 | Maintains | Buy | Get Alert | |
| 10/21/2022 | SCYX | Buy Now | SCYNEXIS | $0.62 | 1188.24% | → $8 | Assumes | → Buy | Get Alert | |
| 03/10/2022 | VRCA | Buy Now | Verrica Pharmaceuticals | $8.00 | 150% | → $20 | Initiates | → Buy | Get Alert | |
| 02/02/2022 | ICCM | Buy Now | Icecure Medical | $0.62 | 814.68% | → $5.65 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved